Israel’s MSICS Pharma is developing medical-grade technology to grow and produce psilocybin, the active compound in psychedelic mushrooms. In trials, psilocybin shows strong potential in treating depression, obsessive-compulsive disorder, plus eating disorders such as anorexia.

https://www.calcalistech.com/ctechnews/article/byoweavrbg